Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 7/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 6/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29631719 | 1.00 | GABRA1 (0.42) | GABRA1GABRG2GABRB3GABRB2FAAH | |
| SCHEMBL14647742 | 0.88 | GABRA1 (0.43) | GABRA1GABRG2GABRB3GABRB2FAAH | |
| SCHEMBL5575889 | 0.85 | GABRA1 (0.43) | GABRA1GABRG2GABRB3GABRB2FAAH | |
| SCHEMBL3962423 | 0.84 | GABRA1 (0.39) | GABRA1GABRG2GABRB3GABRB2FAAH | |
| SCHEMBL398716 | 0.84 | TSHR (0.47) | GABRA1GABRB2HPGDTSHRHTT | |
| Propane SCHEMBL27557470 | 0.82 | GABRA1 (0.48) | GABRA1GABRG2GABRB3GABRB2FAAH | |
| SCHEMBL6313117 | 0.82 | GABRA1 (0.40) | GABRA1GABRB2TSHRHTTELANE | |
| SCHEMBL22415013 | 0.82 | GABRA1 (0.50) | GABRA1GABRG2GABRB3GABRB2FAAH | |
| SCHEMBL27429992 | 0.82 | GABRA1 (0.41) | GABRA1GABRG2GABRB3GABRB2FAAH | |
| SCHEMBL3962086 | 0.81 | SOAT1 (0.39) | GABRA1GABRG2GABRB3GABRB2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0479943-A4 | ADHESIVES AND METHOD FOR MAKING SAME | — | 1992-09-16 | — | — | EP | claimed |
| EP-0479943-A1 | ADHESIVES AND METHOD FOR MAKING SAME | MARTIN MARIETTA ENERGY SYSTEMS, INC. (US) | 1992-04-15 | — | — | EP | claimed |
| WO-1991000308-A1 | ADHESIVES AND METHOD FOR MAKING SAME | MARTIN MARIETTA ENERGY SYSTEMS, INC. (US) | 1991-01-10 | — | — | WO | claimed |
| EP-4543894-A1 | NOVEL RUTHENIUM COMPLEXES, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS USED IN THIS METHOD, METHOD OF THEIR SYNTHESIS AND THE USE OF NOVEL RUTHENIUM COMPLEXES IN OLEFIN METATHESIS REACTIONS | Uniwersytet Warszawski (PL) | 2025-04-30 | — | — | EP | disclosed |
| CN-118974107-A | Maleimide compound, curable resin composition, cured product thereof, amine compound, and reactant of amine compound and maleic anhydride | 日本化药株式会社 | 2024-11-15 | — | — | CN | disclosed |
| US-12054578-B2 | Process for producing porous materials | AEROGEL-IT GMBH (DE) | 2024-08-06 | — | — | US | disclosed |
| CN-113260646-B | Aromatic amine resin, maleimide resin, curable resin composition, and cured product thereof | 日本化药株式会社 | 2024-04-02 | — | — | CN | disclosed |
| WO-2023248205-A1 | NOVEL RUTHENIUM COMPLEXES, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS USED IN THIS METHOD, METHOD OF THEIR SYNTHESIS AND THE USE OF NOVEL RUTHENIUM COMPLEXES IN OLEFIN METATHESIS REACTIONS | UNIWERSYTET WARSZAWSKI (PL) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023189411-A1 | MALEIMIDE COMPOUND, CURABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF, AMINE COMPOUND AND REACTION PRODUCT OF AMINE COMPOUND WITH MALEIC ANHYDRIDE | 日本化薬株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-11766436-B2 | KRAS G12C inhibitors and methods of using the same | AMGEN INC. (US) | 2023-09-26 | — | — | US | disclosed |
| US-20230255101-A1 | Tetradentate Metal Complexes with Carbon Group Bridging Ligands | UNIV ARIZONA STATE (US) | 2023-08-10 | — | — | US | disclosed |
| EP-0055363-B1 | PERYLENE TETRACARBOXYLIC-ACID DIIMIDES AND THEIR USE | BASF Aktiengesellschaft (DE) | 1983-12-14 | — | — | EP | disclosed |
| US-4401833-A | Process for the preparation of 4-chloro-2,6-dialkylanilines | BAYER AKTIENGESELLSCHAFT (DE) | 1983-08-30 | — | — | US | disclosed |
| EP-0068138-A1 | Chloroacetanilide, process for its preparation and herbicidal agents containing it | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-01-05 | — | — | EP | disclosed |
| EP-0055363-A1 | Perylene tetracarboxylic-acid diimides and their use | BASF Aktiengesellschaft (DE) | 1982-07-07 | — | — | EP | disclosed |
| EP-0052817-A1 | Process for the preparation of 4-chloro-2,6 dialkyl anilines | BAYER AG (DE) | 1982-06-02 | — | — | EP | disclosed |
| US-4289906-A | Chemical process for preparing methylene bis-anilines | ETHYL CORPORATION (US) | 1981-09-15 | — | — | US | disclosed |
| US-4194008-A | INSECTICIDE, FUNGICIDE, MITICIDE, PARASITICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1980-03-18 | — | — | US | disclosed |
| EP-0003101-A1 | Substituted N-cyclohexyl isothiourea, their preparation and their use as pesticides | BAYER AG (DE) | 1979-07-25 | — | — | EP | disclosed |
| EP-0000365-A1 | N-aryl-N'-alcoyl-S-alcoyl isothioureas, process for their preparation and their use against animal and vegetal pests | BAYER AG (DE) | 1979-01-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255101-A1 | Tetradentate Metal Complexes with Carbon Group Bridging Ligands | STAU1, POLR1G, CLTC | GABRA1 1810/4885GABRG2 2094/4885GABRB3 1319/4885 |
| US-11766436-B2 | KRAS G12C inhibitors and methods of using the same | KRAS, NRAS, HRAS | GABRA1 4420/4885GABRG2 2943/4885GABRB3 4532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.